| Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 ... - Bradenton Herald |
|
|
Bradenton Herald ... a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease (the "Company"), ... Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and |